219 related articles for article (PubMed ID: 26797898)
1. Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis.
Ma Q; Zhao Z; Barber BL; Shilkrut M
Adv Ther; 2016 Feb; 33(2):282-9. PubMed ID: 26797898
[TBL] [Abstract][Full Text] [Related]
2. Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
Dossett LA; Ben-Shabat I; Olofsson Bagge R; Zager JS
Ann Surg Oncol; 2016 Jul; 23(7):2330-5. PubMed ID: 26926481
[TBL] [Abstract][Full Text] [Related]
3. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
4. Isolated limb infusion for malignant melanoma: predictors of response and outcome.
Barbour AP; Thomas J; Suffolk J; Beller E; Smithers BM
Ann Surg Oncol; 2009 Dec; 16(12):3463-72. PubMed ID: 19830498
[TBL] [Abstract][Full Text] [Related]
5. Isolated limb perfusion and infusion in the treatment of melanoma and soft tissue sarcoma in the era of modern systemic therapies.
Song Y; Bruce AN; Fraker DL; Karakousis GC
J Surg Oncol; 2019 Sep; 120(3):540-549. PubMed ID: 31267571
[TBL] [Abstract][Full Text] [Related]
6. Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
Coventry BJ; Kroon HM; Giles MH; Henderson M; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM
J Surg Oncol; 2014 Jun; 109(8):780-5. PubMed ID: 24634160
[TBL] [Abstract][Full Text] [Related]
7. Outcomes following isolated limb infusion for melanoma. A 14-year experience.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2008 Nov; 15(11):3003-13. PubMed ID: 18509706
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of isolated limb infusion with cytotoxic drugs in elderly patients with advanced locoregional melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg; 2009 Jun; 249(6):1008-13. PubMed ID: 19474677
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy and toxicity of upper extremity isolated limb infusion chemotherapy for melanoma: An Australian multi-center study.
Kroon HM; Coventry BJ; Henderson MA; Barbour A; Serpell J; Smithers BM; Thompson JF
Eur J Surg Oncol; 2019 May; 45(5):832-837. PubMed ID: 30867095
[TBL] [Abstract][Full Text] [Related]
10. Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients.
Takkenberg RB; Vrouenraets BC; van Geel AN; Nieweg OE; Noorda EM; Eggermont AM; Kroon BB
J Surg Oncol; 2005 Aug; 91(2):107-11. PubMed ID: 16028280
[TBL] [Abstract][Full Text] [Related]
11. Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
Kroon HM; Coventry BJ; Giles MH; Henderson MA; Speakman D; Wall M; Barbour A; Serpell J; Paddle P; Coventry AG; Sullivan T; Smithers BM; Thompson JF
Ann Surg Oncol; 2016 Apr; 23(4):1096-103. PubMed ID: 26581203
[TBL] [Abstract][Full Text] [Related]
12. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
13. Melphalan in regional chemotherapy for locally recurrent metastatic melanoma.
Defty CL; Marsden JR
Curr Top Med Chem; 2012; 12(1):53-60. PubMed ID: 22196271
[TBL] [Abstract][Full Text] [Related]
14. The role of regional chemotherapy for advanced limb melanoma in the era of potentially effective systemic therapies.
Read RL; Thompson JF
Melanoma Res; 2021 Aug; 31(4):290-297. PubMed ID: 34039942
[TBL] [Abstract][Full Text] [Related]
15. Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy.
Grünhagen DJ; Kroon HM; Verhoef C
Am Soc Clin Oncol Educ Book; 2015; ():e528-34. PubMed ID: 25993219
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
Koops HS; Vaglini M; Suciu S; Kroon BB; Thompson JF; Göhl J; Eggermont AM; Di Filippo F; Krementz ET; Ruiter D; Lejeune FJ
J Clin Oncol; 1998 Sep; 16(9):2906-12. PubMed ID: 9738557
[TBL] [Abstract][Full Text] [Related]
17. Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs.
Klop WM; Vrouenraets BC; van Geel BN; Eggermont AM; Klaase JM; Nieweg OE; Kroon BB
J Am Coll Surg; 1996 Jun; 182(6):467-72. PubMed ID: 8646345
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma.
Lindnér P; Doubrovsky A; Kam PC; Thompson JF
Ann Surg Oncol; 2002 Mar; 9(2):127-36. PubMed ID: 11888868
[TBL] [Abstract][Full Text] [Related]
19. The role of regional chemotherapy in the management of extremity soft tissue malignancies.
Smith HG; Hayes AJ
Eur J Surg Oncol; 2016 Jan; 42(1):7-17. PubMed ID: 26382102
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
Miura JT; Kroon HM; Beasley GM; Mullen D; Farrow NE; Mosca PJ; Lowe MC; Farley CR; Kim Y; Naqvi SMH; Potdar A; Daou H; Sun J; Farma JM; Henderson MA; Speakman D; Serpell J; Delman KA; Mark Smithers B; Coventry BJ; Tyler DS; Thompson JF; Zager JS
Ann Surg Oncol; 2019 Aug; 26(8):2486-2494. PubMed ID: 30911949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
